Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Colorectal Neoplasms × sacituzumab govitecan × Clear all

Phase

Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Oxaliplatin 15 Fluorouracil 13 Bevacizumab 11 Leucovorin 10 Capecitabine 8 Folfox protocol 7 Irinotecan 5 IFL protocol 4 Cetuximab 4 Folic Acid 3 Aspirin 3 XELOX 2 Surgical Procedures, Operative 2 Magnetic Resonance Spectroscopy 2 Drug Therapy 2 Chemotherapy, Adjuvant 2 trifluridine tipiracil drug combination 1 trametinib 1 titanium silicide 1 sulindac sulfone 1 spartalizumab 1 sacituzumab govitecan 1 regorafenib 1 pertuzumab 1 folfirinox 1 dabrafenib 1 cobimetinib 1 cediranib 1 atezolizumab 1 anlotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06243393 2024-07-10

TROPHIT1

University Hospital Heidelberg

Phase 2/3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡